Cell Therapy Market Report (2021-2031) | The Insight Partners
The cell therapy market size is projected to reach US$ 16.72 billion by 2031 from US$ 9.59 billion in 2023. The market is expected to register a CAGR of 7.2% during 2023–2031. Advancements in cell-based therapeutics and the introduction of novel products by key manufacturers will likely remain key trends in the cell therapy market.
Cell Therapy Market Analysis
Regenerative therapies induce the regeneration of cells, tissues, and organs, followed by aiding the restoration of their functions. According to the Alliance for Regenerative Medicine, 520 clinical trials utilizing cell therapy medicine were underway globally (192 Phase I, 125 Phase II, 36 Phase III) as of Q4 2023. Further, the approval and commercialization of Kymriah in 2017, the first cell therapy of its kind, is marked as a significant event contributing to the continued prominence of cell therapy in the field of cell and gene therapy (C>). The development of CAR-T cell (i.e., chimeric antigen receptor T cell) therapy has transformed the approach to the treatment of some cancers. CAR-T cell therapies have been the subject of the most research and innovation efforts worldwide; five additional products based on this technology, i.e., Yescarta, Abecma, Tecartus, Breyanzi, and Carvykti, have been approved for the treatment of various blood cancers. Thus, the expanding range of regenerative medicine applications fuels the cell therapy market growth.
Cell Therapy Market Overview
CAR T-cell therapy has been proven to be a promising method for treating cancer. Every year, a huge number of preclinical and clinical trials are conducted to study its use in newer therapeutic applications. In addition to autologous and allogeneic products, new in-vivo CAR-T cell gene therapies and their efficacy in indications other than hematologic malignancies are likely to be the prime focus of research in the future.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell Therapy Market: Strategic Insights
Market Size Value in US$ 7,260.50 million in 2019 Market Size Value by US$ 12,563.23 million by 2027 Growth rate CAGR of 7.2% from 2020 to 2027 Forecast Period 2020-2027 Base Year 2019
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell Therapy Market: Strategic Insights
| Market Size Value in | US$ 7,260.50 million in 2019 |
| Market Size Value by | US$ 12,563.23 million by 2027 |
| Growth rate | CAGR of 7.2% from 2020 to 2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2019 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Cell Therapy Market Drivers and Opportunities
Increase in Prevalence of Cancer Favors Market Growth
A sedentary lifestyle, changes in dietary habits, etc., are well-known risk factors for prominent chronic diseases such as neurological disorders, cancer, autoimmune diseases, and cardiovascular diseases. According to the Centers for Disease Control and Prevention, one or more chronic illnesses, including diabetes, cancer, heart disease, or stroke, affect 6 out of every 10 Americans. Chronic illnesses are among the main causes of death and disability in the US. Genetic predisposition, processed food, pollution, and altered lifestyles are the factors contributing to the surging prevalence of cancer. According to the American Cancer Society, nearly 19.3 million new cancer cases were registered globally in 2020. Cell therapy has emerged as a new cancer treatment method in the last few decades. T cells are modified in a laboratory setup and then administered into the body to target cancer cells. CAR-T cell therapy is employed to treat adult and pediatric leukemia cases, and a few types of lymphoma. Additionally, it is being researched as a potential treatment for other cancer conditions, including solid tumors developing in the chest. Thus, an increase in the number of patients suffering from cancer drives the demand for CAR-T cell therapies, thereby contributing to the growth of the cell therapy market.
Research and Development Funding
Researchers are motivated to investigate ways to enhance the effectiveness of cell therapy due to the complete response rates and progression-free survival observed in patients with relapsed/refractory malignancies who had received prior treatment. Researchers are looking into elements such as antigen loss that could lead to immune escape and are coming up with ways to deal with them. Designing cell therapies to simultaneously target several antigens is one beneficial approach. The California Institute for Regenerative Medicine (CIRM), the largest regenerative medicine organization in the world, has granted US$ 43.8 million to power initiatives supporting gene therapy and stem cell research in California. The award supports the projects in clinical, discovery, and infrastructure programs of the institute.
Cell Therapy Market Report Segmentation Analysis
Key segments contributing to the derivation of the cell therapy market analysis are therapy type, product, technology, application, and end user.
- Based on therapy type, the cell therapy market is divided into allogeneic and autologous. The allogeneic segment held a larger market share in 2023.
- By product, the market is segmented into consumables, equipment, and systems and software. The equipment segment held the largest share of the market in 2023.
- In terms of technology, the market is divided into viral vector technology, genome editing technology, somatic cell technology, cell immortalization technology, cell plasticity technology, and three-dimensional technology.
- By application, the market is segmented into oncology, cardiovascular, orthopedic, wound management, and other applications. The oncology segment held the largest share of the market in 2023.
- Based on end user, the cell therapy market is categorized into research institutes, hospitals, and others. The hospitals segment held the largest market share in 2023.
Cell Therapy Market Share Analysis by Geography
The geographic scope of the cell therapy market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. North America dominates the market. In North America, the US held the largest share of the cell therapy market in 2023. Market growth is attributed to the increased research and development, coupled with the surging adoption of cell therapies such as stem cell, gene, and immune therapies. Rising incidences of genetic and cellular disorders, and burgeoning focus on expanding the development and manufacturing capacities of cell therapies further favor the cell therapy market progress. Bayer AG has established its first Cell Therapy Launch Facility in Berkeley to enable the delivery of cell therapies to patients worldwide. The US$ 250 million, 100,000-square-foot facility will provide the materials needed for late-stage clinical trials to facilitate the commercial launch of bemdaneprocel (BRT-DA01), an experimental cell therapy being tested by BlueRock Therapeutics to treat Parkinson's disease and other conditions. Asia Pacific is anticipated to record the highest CAGR in the cell therapy market during the forecast period.
Cell Therapy Market Report Scope
Cell Therapy Market News and Recent Developments
The cell therapy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in cell therapy market are listed below:
- Ginkgo Bioworks, a company engaged in building a leading platform for cell programming and biosecurity, announced the acquisition of Modulus Therapeutics' cell therapy platform assets, including their CAR and switch receptor libraries. (Source: Ginkgo Bioworks Company Name, Press Release, 2024)
- AstraZeneca entered into a definitive agreement to acquire Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company developing innovative cell therapies for the treatment of cancer and autoimmune diseases. (Source: AstraZeneca Company Name, Press ReleaseNewsletter, 2024)
Cell Therapy Market Report Coverage and Deliverables
The “Cell Therapy Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Cell therapy market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Cell therapy market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Cell therapy market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the cell therapy market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Therapy Type, Product, Technology, Application, End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For